ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Tecentriq 1200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung - 
66152001 Roche Pharma (Schweiz) AG
Tecentriq 1200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung23.05.2017
  23.05.2017
(L01FF05) 
WHO-DDD 
07.16.10. 
07.16.10. 
A  
Yes 
IP 
4370.35Yes
    
10 %4730.20
  
7680661520012Biotechnologika
7073568 
Composition
atezolizumabum 1200 mg, histidinum, acidum aceticum glaciale, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 20 ml.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Atezolizumabum1200mg / 20ml
BAG: Active AgentDose
Atezolizumabum1200 mg
 
Inactive agents
Acidum Aceticum Glaciale
Histidine
Polysorbatum 20
Saccharum
 
Source
Data was imported : 06.04.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home